From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.

Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by ...

If granted, IXCHIQ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and ...

Q4 2024 Earnings Call Transcript February 27, 2025 GoodRx Holdings, Inc. misses on earnings expectations. Reported EPS is ...

Q4 2024 Earnings Call Transcript February 27, 2025 Cardiff Oncology, Inc. beats earnings expectations. Reported EPS is $-0.22 ...

Indeed, the ambitious project — which involves a $27 billion investment — comes as pharmaceutical executives try to navigate ...

Banco Santander, S.A. (the "Company") today announced that it filed its 2024 Annual Report on Form 20-F ("Form 20-F") with the U.S. Securities and Exchange Commission. The Form 20-F is available on ...

Ovation Healthcare, a premier provider of shared services that improve hospital and system performance, has announced the ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

Gene therapy maker bluebird bio’s 15-year flight has landed in the nest of private equity firms Carlyle and SK Capital in a ...

In the waning days of the Biden administration, the Labor Department added ovarian, uterine, cervical, and breast cancer coverage for wildland firefighters. It’s unclear whether the new protections ...